Asymptomatic atrial fibrillation in symptomatic patients

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 8, 2004, Pages 925-926

  Callans, David J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CATHETER ABLATION; CLINICAL TRIAL; DECISION MAKING; EVALUATION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTENSIVE CARE; NOTE; PACEMAKER; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 4444228389     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04345.x     Document Type: Note

References (9)

1. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
2. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Camp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-1840.
3. Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, Han J, Fortino J, Chugh A, Bogun F, Pelosi F Jr, Morady F: Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency ablation. J Cardiovasc Electrophysiol 2004;15:920-924.
4. Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE: Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: Implications for ablation strategies. J Cardiovasc Electrophysiol 2003;14:685-690.
5. Page RL, Wilkinson WE, Clair WK: Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.
6. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL: Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation 2003;107:1141-1145.
7. Israel CW, Grönefeld G, Erhlich JR, Li Y-G, Hohnloser SH: Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol 2004;43:47-52.
8. Timmermans C, Levy S, Ayers GM, Jung W, Jordaens L, Rosenquist M, Thibault B, Camm J, Rodriquez L-M, Wellens HJJ: Spontaneous episodes of atrial fibrillation after implantation of the Metrix Cardioverter: Observations on treated and nontreated episodes. J Am Coll Cardiol 2000;35:1428-1433.
9. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo C, Gent M, VPS II Investigators: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA 2003;289:2224-2229.